ARTICLE | Clinical News
SyB D-0701: Phase I completed
August 4, 2008 7:00 AM UTC
SymBio completed a pair of Japanese Phase I trials. The company has exclusive rights to SyB D-0701 in Japan and other East Asian countries from Abeille, which is developing it as AB-1001. ...